Dr. Bernton has worked for more than 15 years in the field of clinical pharmacology and early-phase drug development.
He is currently a consultant to small biotech companies, assisting with the early-stage development of new vaccines and new treatments for cancer and autoimmune diseases.
He previously served five years as Scientific Director for the PAREXEL Clinical Pharmacology Network in North America and has been the research protocol author or clinical investigator on over 30 clinical trials including many first-in-man studies for novel small molecules, biopharmaceutics, and vaccines and several oncology trials.
Dr. Bernton's medical subspecialties include internal medicine, allergy/immunology, and clinical immunology.
Dr. Bernton received his MD from Georgetown University in 1978 and is board-certified in Internal Medicine and Allergy/Immunology/Asthma. He served 20 years in the U.S. Army Medical Corps, including 12 years doing basic and clinical research at the Walter Reed Army Institute of Research. He has authored or co-authored over 35 research publications in scientific journals.
